Correlation Between Defence Therapeutics and Cyteir Therapeutics
Can any of the company-specific risk be diversified away by investing in both Defence Therapeutics and Cyteir Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Defence Therapeutics and Cyteir Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Defence Therapeutics and Cyteir Therapeutics, you can compare the effects of market volatilities on Defence Therapeutics and Cyteir Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Defence Therapeutics with a short position of Cyteir Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Defence Therapeutics and Cyteir Therapeutics.
Diversification Opportunities for Defence Therapeutics and Cyteir Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Defence and Cyteir is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Defence Therapeutics and Cyteir Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyteir Therapeutics and Defence Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Defence Therapeutics are associated (or correlated) with Cyteir Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyteir Therapeutics has no effect on the direction of Defence Therapeutics i.e., Defence Therapeutics and Cyteir Therapeutics go up and down completely randomly.
Pair Corralation between Defence Therapeutics and Cyteir Therapeutics
If you would invest 75.00 in Defence Therapeutics on December 1, 2024 and sell it today you would earn a total of 4.00 from holding Defence Therapeutics or generate 5.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Defence Therapeutics vs. Cyteir Therapeutics
Performance |
| Timeline |
| Defence Therapeutics |
| Cyteir Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Defence Therapeutics and Cyteir Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Defence Therapeutics and Cyteir Therapeutics
The main advantage of trading using opposite Defence Therapeutics and Cyteir Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Defence Therapeutics position performs unexpectedly, Cyteir Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyteir Therapeutics will offset losses from the drop in Cyteir Therapeutics' long position.| Defence Therapeutics vs. Sino Biopharmaceutical Ltd | Defence Therapeutics vs. Institute of Biomedical | Defence Therapeutics vs. Enlivex Therapeutics | Defence Therapeutics vs. Lixte Biotechnology Holdings |
| Cyteir Therapeutics vs. Nuvation Bio | Cyteir Therapeutics vs. Foghorn Therapeutics | Cyteir Therapeutics vs. C4 Therapeutics | Cyteir Therapeutics vs. Prelude Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |